TY - JOUR T1 - Comparative Docking to Distinct G Protein–Coupled Receptor Conformations Exclusively Yields Ligands with Agonist Efficacy JF - Molecular Pharmacology JO - Mol Pharmacol SP - 851 LP - 861 DO - 10.1124/mol.119.117515 VL - 96 IS - 6 AU - Magdalena M. Scharf AU - Moritz Bünemann AU - Jillian G. Baker AU - Peter Kolb Y1 - 2019/12/01 UR - http://molpharm.aspetjournals.org/content/96/6/851.abstract N2 - G protein–coupled receptors exist in a whole spectrum of conformations that are stabilized by the binding of ligands with different efficacy or intracellular effector proteins. Here, we investigate whether three-dimensional structures of receptor conformations in different states of activation can be used to enrich ligands with agonist behavior in prospective docking calculations. We focused on the β2-adrenergic receptor, as it is currently the receptor with the highest number of active-state crystal structures. Comparative docking calculations to distinct conformations of the receptor were used for the in silico prediction of ligands with agonist efficacy. The pharmacology of molecules selected based on these predictions was characterized experimentally, resulting in a hit rate of 37% ligands, all of which were agonists. The ligands furthermore contain a pyrazole moiety that has previously not been described for β2-adrenergic receptor ligands, and one of them shows an intrinsic efficacy comparable to salbutamol.SIGNIFICANCE STATEMENT Structure-based ligand design for G protein–coupled receptors crucially depends on receptor conformation and, hence, their activation state. We explored the influence of using multiple active-conformation X-ray structures on the hit rate of docking calculations to find novel agonists, and how to predict the most fruitful strategy to apply. The results suggest that aggregating the ranks of molecules across docking calculations to more than one active-state structure exclusively yields agonists. ER -